Companies: 10,795·Total market cap: $144.5T
AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc.

ANTXNASDAQHealthcare● Active
$3.85
+$0.03(+0.79%)
Market Cap$105497792
P/E Ratio
52W High$6.91
52W Low$1
Overview

AN2 Therapeutics, Inc. (ANTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ANTX · as of Mar 17, 2026

Latest filing snapshot

21
-1-4.55%vs prior year

AN2 Therapeutics, Inc. (ANTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
21
Change (1Y)
-1
Growth % (1Y)
-4.55%
Revenue / Employee
Net Income / Employee
$-1.67M
Market Cap
$105M

ANTX Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1721-1-4.55%
2025-03-2522-19-46.34%
2024-03-2941+6+17.14%
2023-03-2935

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Pluri Inc.
PLUR
Pluri Inc.
106
#2
Boundless Bio, Inc.
BOLD
Boundless Bio, Inc.
64
#3
NextCure, Inc.
NXTC
NextCure, Inc.
43
#4
AN2 Therapeutics, Inc.
ANTX
AN2 Therapeutics, Inc.YOU
21
#5
iBio, Inc.
IBIO
iBio, Inc.
16
#6
Iterum Therapeutics plc
ITRM
Iterum Therapeutics plc
9
#7
Intensity Therapeutics, Inc.
INTS
Intensity Therapeutics, Inc.
5
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ANTX peer comparison

About ANTX employees

ANTX Employees · Headcount

AN2 Therapeutics, Inc. (ANTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, AN2 Therapeutics, Inc. had 21 full-time employees globally. Full-time employees only. Global consolidated headcount.

AN2 Therapeutics, Inc.'s workforce decreased by 1 (4.55%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

ANTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), AN2 Therapeutics, Inc. had 21 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

AN2 Therapeutics, Inc. employee counthow many employees does AN2 Therapeutics, Inc. haveANTX total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-17